AU2002226955B2 - Pharmaceutical dosage form with multiple coatings - Google Patents

Pharmaceutical dosage form with multiple coatings Download PDF

Info

Publication number
AU2002226955B2
AU2002226955B2 AU2002226955A AU2002226955A AU2002226955B2 AU 2002226955 B2 AU2002226955 B2 AU 2002226955B2 AU 2002226955 A AU2002226955 A AU 2002226955A AU 2002226955 A AU2002226955 A AU 2002226955A AU 2002226955 B2 AU2002226955 B2 AU 2002226955B2
Authority
AU
Australia
Prior art keywords
coating layer
poly
methacrylic acid
methyl methacrylate
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2002226955A
Other languages
English (en)
Other versions
AU2002226955A1 (en
Inventor
Joseph Michael Amante
Tony Ryan Cronk
Gregory Paul Dittmar
Daniel Gary Newby
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Pharmaceuticals International Ltd
Original Assignee
Allergan Pharmaceuticals International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32823137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2002226955(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Pharmaceuticals International Ltd filed Critical Allergan Pharmaceuticals International Ltd
Publication of AU2002226955A1 publication Critical patent/AU2002226955A1/en
Application granted granted Critical
Publication of AU2002226955B2 publication Critical patent/AU2002226955B2/en
Assigned to WARNER CHILCOTT COMPANY, LLC reassignment WARNER CHILCOTT COMPANY, LLC Request for Assignment Assignors: THE PROCTER & GAMBLE COMPANY
Assigned to ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED reassignment ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED Request for Assignment Assignors: WARNER CHILCOTT COMPANY, LLC
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002226955A 2001-11-23 2001-11-23 Pharmaceutical dosage form with multiple coatings Expired AU2002226955B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/043893 WO2003045356A1 (en) 2000-11-20 2001-11-23 Pharmaceutical dosage form with multiple coatings

Publications (2)

Publication Number Publication Date
AU2002226955A1 AU2002226955A1 (en) 2003-06-10
AU2002226955B2 true AU2002226955B2 (en) 2006-04-27

Family

ID=32823137

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226955A Expired AU2002226955B2 (en) 2001-11-23 2001-11-23 Pharmaceutical dosage form with multiple coatings

Country Status (15)

Country Link
EP (1) EP1453487B2 (enExample)
JP (1) JP4999037B2 (enExample)
CN (1) CN1314390C (enExample)
AT (1) ATE389389T1 (enExample)
AU (1) AU2002226955B2 (enExample)
BR (1) BRPI0117180B8 (enExample)
DE (1) DE60133319T3 (enExample)
DK (1) DK1453487T3 (enExample)
ES (1) ES2301575T5 (enExample)
HU (1) HU231030B1 (enExample)
IL (1) IL161628A (enExample)
MX (1) MXPA04004747A (enExample)
NZ (1) NZ532564A (enExample)
PT (1) PT1453487E (enExample)
WO (1) WO2003045356A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
PT2446881E (pt) * 2003-07-24 2014-06-11 Glaxosmithkline Llc Películas de dissolução oral
GB2407501A (en) * 2003-11-03 2005-05-04 Ist Superiore Sanita Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
ES2323536T3 (es) * 2004-09-01 2009-07-20 The Procter And Gamble Company Composiciones que comprenden acido-5-amino-2-hidroxibenzoico yh un azucar reductor.
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
PL2152250T3 (pl) 2007-05-07 2020-06-15 Evonik Röhm Gmbh Stałe postaci dawkowania zawierające otoczkę dojelitową o przyspieszonym uwalnianiu leku
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
JP2012107058A (ja) * 2012-02-27 2012-06-07 Warner Chilcott Co Llc 複数のコーティングを有する医薬剤形
US20140141075A1 (en) * 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
GB2510754B (en) * 2013-02-12 2016-07-13 Diurnal Ltd Controlled drug release
TWI688411B (zh) * 2013-02-22 2020-03-21 日商志瑞亞新藥工業股份有限公司 腸溶錠
JP6165022B2 (ja) * 2013-10-30 2017-07-19 株式会社ファンケル 放出制御型ソフトカプセル剤
WO2016001843A1 (en) * 2014-06-30 2016-01-07 Sun Pharmaceutical Industries Limited Extended-release gastroretentive tablets of voglibose
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN107661370A (zh) * 2017-11-20 2018-02-06 贵州浩诚药业有限公司 一种苦参片及其制备方法
JP2021528483A (ja) * 2018-05-03 2021-10-21 エムダブリュ エンキャップ リミテッド 下部胃腸管への医薬の送達のための剤形
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
CN113993509A (zh) * 2019-05-15 2022-01-28 赢创运营有限公司 用胶囊填充机制备具有基于(甲基)丙烯酸酯共聚物的包衣的填充硬壳胶囊的方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366621A1 (en) * 1988-10-20 1990-05-02 BOEHRINGER INGELHEIM ITALIA S.p.A. Orally pharmaceutical preparations with colon selective delivery
WO1998027967A1 (en) * 1996-12-20 1998-07-02 Dumex-Alpharma A/S Release-controlled coated tablets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
CN1239425A (zh) * 1996-11-15 1999-12-22 普罗克特和甘保尔公司 供结肠释放的具有多层肠溶聚合物包衣的药剂

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366621A1 (en) * 1988-10-20 1990-05-02 BOEHRINGER INGELHEIM ITALIA S.p.A. Orally pharmaceutical preparations with colon selective delivery
WO1998027967A1 (en) * 1996-12-20 1998-07-02 Dumex-Alpharma A/S Release-controlled coated tablets

Also Published As

Publication number Publication date
DK1453487T3 (da) 2008-07-21
ES2301575T5 (es) 2022-04-22
AU2002226955A1 (en) 2003-06-10
IL161628A0 (en) 2004-09-27
EP1453487B1 (en) 2008-03-19
MXPA04004747A (es) 2004-08-02
DE60133319D1 (de) 2008-04-30
NZ532564A (en) 2006-06-30
HUP0402230A2 (hu) 2005-02-28
BRPI0117180B1 (pt) 2018-12-04
WO2003045356A1 (en) 2003-06-05
BRPI0117180B8 (pt) 2021-05-25
EP1453487B2 (en) 2021-03-31
HUP0402230A3 (en) 2008-04-28
ATE389389T1 (de) 2008-04-15
BR0117180A (pt) 2004-11-03
DE60133319T2 (de) 2009-04-30
DE60133319T3 (de) 2021-08-05
CN1314390C (zh) 2007-05-09
HU231030B1 (hu) 2019-12-30
CN1558754A (zh) 2004-12-29
JP4999037B2 (ja) 2012-08-15
ES2301575T3 (es) 2008-07-01
JP2005510539A (ja) 2005-04-21
PT1453487E (pt) 2008-05-13
IL161628A (en) 2014-03-31
EP1453487A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
US9089492B2 (en) Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
AU2002226955A1 (en) Pharmaceutical dosage form with multiple coatings
US5686105A (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
EP0827398B1 (en) Pharmaceutical dosage form for colonic delivery
CA2268175C (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5843479A (en) Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
WO1996036338A1 (en) Bisacodyl dosage form for colonic delivery
CA2271569C (en) Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
CA2444814C (en) Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
CA2271560C (en) Pharmaceutical dosage form for colonic delivery
JP2012107058A (ja) 複数のコーティングを有する医薬剤形

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: WARNER CHILCOTT COMPANY, LLC

Free format text: FORMER OWNER WAS: THE PROCTER & GAMBLE COMPANY

PC Assignment registered

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED

Free format text: FORMER OWNER(S): WARNER CHILCOTT COMPANY, LLC

MK14 Patent ceased section 143(a) (annual fees not paid) or expired